UCSF University of California, San Francisco      About UCSF       Search UCSF       UCSF Medical Center     
  Education & Training    Research    Patient Care   
 School Campuses
 Dean's Office Units
Continuing Medical Education
Course Catalog
Grand Rounds
CME Planners' Resources
CME Resources
CME News
About Continuing Medical Education

11th Annual UCSF/UC Davis Thoracic Oncology Conference

Open PDF brochure


The course you selected is now closed to online registration. Please call 415.476.5808 to ask about how to register at the course.

Department: Surgery
Course Number: MSU10004
Start: Saturday, November 21, 2009
End: Saturday, November 21, 2009
Location: San Francisco, California
The St. Regis Hotel San Francisco
Fees: $175 - Physicians
$90 - Allied Health Professionals, Nurses, Residents, Fellows

Upcoming Related CME program: 9th Annual Clinical Cancer Update, January 29-30, 2010 , The Resort at Squaw Creek, North Lake Tahoe.

*Attendees who register for both courses will receive a $50.00 discount off of the registration for the Clinical Cancer Update course.
UCSF Association of Clinical Faculty Vouchers are accepted for this course. For more information please call the Office of Continuing Medical Education at 415-476-4251. 
Credit: 8 AMA PRA Category 1 Credit(s)™

The 11th Annual UCSF/UC Davis Thoracic Oncology Conference will be held on Saturday, November 21, 2009 highlighting updates in lung cancer and mesothelioma and will feature national leaders in the field. The intended audience is practicing physicians and nurses in the areas of internal medicine, oncology, radiation oncology, pulmonology, and surgery in the Bay Area and Northwestern United States. The conference is being offered through the UCSF Office of Continuing Medical Education, an accredited CME provider. The date of this conference is coordinated with National Lung Cancer Awareness Month, in November.

   Back To Top

At the conclusion of the course an attendee should be able to:

  • Incorporate the use of adjuvant radiation therapy in the treatment of lung cancer when indicated;
  • Identify the latest combined modality therapies available for patients with lung cancer, and esophageal cancer;
  • Improve patient consultation on available treatment options and clinical trials;
  • Incorporate emerging therapies for lung cancer, esophageal cancer and mesothelioma in the management and care of patients;
  • Integrate inhibitors of the EGFR pathway into clinical practice;
  • Increase awareness of molecular-targeted therapies that are being developed in lung cancer, including angiogenesis inhibitors and tyrosine kinase inhibitors;
  • Improve professional competence in the surgical treatment of lung cancer and esophageal cancer;
  • Incorporate appropriate use of Cyberknife Radiotherapy for advanced stage lung disease.

   Back To Top

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this educational activity for a maximum of 8 AMA PRA Category 1 CreditsTM.

Physician should only claim credit commensurate with the extent of their participation in the activity.

This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and linguistic competency.

For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)TM issued by organizations accredited by the ACCME.

   Back To Top

Course Outline:
For course slides, please visit this link.


7:30 am Registration, Continental Breakfast, and Exhibits

8:00 Welcome and Introduction
David M. Gandara, MD
David Jablons, MD

Chair: David M. Gandara, MD
Panel: Michele Carbone, MD, PhD / Sarita Dubey, MD / Alexander Gottschalk, MD, PhD / Heather Wakelee, MD


8:10 Asbestos and Erionite Carcinogenesis
Michele Carbone, MD, PhD

8:35 Questions

8:40 Anti-Angiogenesis Agents in NSCLC
Heather Wakelee, MD

8:55 Questions

9:00 Cyberknife Options in Advanced Disease
Alexander Gottschalk, MD, PhD

9:15 Questions

9:20 Novel Agents for Advanced NSCLC
Sarita Dubey, MD

9:35 Questions

9:40 Case Presentation/Roundtable Discussion
Moderator: Kenneth Yoneda, MD

10:10 Break

Chair: Lorriana Leard, MD
Panel: David Gandara, MD / Primo “Lucky” Lara, MD / Tina Li, MD / Sue Yom, MD

10:25 Decision-Making Process for Lung Cancer
David M. Gandara, MD

10:40 Questions

10:45 The Need For New Paradigms in Stage III NSCLC Improving Combined Modality Approaches
Primo N. “Lucky” Lara, MD

11:00 Questions

11:05 Case Presentation/Roundtable Discussion
Moderator: Allen Chen, MD

Chair: David Cooke, MD
Panel: Guilherme Campos, MD / Andrew Ko, MD / Derick Lau, MD / Pierre Theodore, MD

11:35 Tumors Below the GE Junction - Operative Management and Strategies
Guilherme M. Campos, MD

11:50 Questions

11:55 Multi-Disciplinary Management of Esophageal Cancer
Pierre Theodore, MD

12:10 pm Questions

12:15 Case Presentation/Roundtable Discussion
Case Presenter: Andrew Ko, MD

12:45 Break/Boxed Lunches

Chair: Sue S. Yom, MD
Panel: Royce Calhoun, MD / David Jablons, MD / Thierry Jahan, MD / Jasleen Kukreja, MD / David Shelton, MD

1:15 Subanatomic Resection for Early Stage NSCLC
Royce Calhoun, MD

1:35 Questions

1:40 Spiral CT Screening- ACRIN Trial and World Perspective
David K. Shelton, Jr., MD

1:55 Questions

2:00 Neoadjuvant Chemotherapy: Has Its Time Come?
David M. Jablons, MD

2:15 Questions

2:20 Role of the Pulmonologist in a Multidisciplinary Thoracic Program
Kenneth Yoneda, MD

2:35 Questions

2:40 Case Presentation/Roundtable Discussion
Moderator: Jasleen Kukreja, MD

3:10 Break

3:25 World Perspective on the Treatment of Mesothelioma
Thierry M. Jahan, MD

3:40 Questions

Chair: Philip Mack, PhD
Panel: Michele Carbone, MD, PhD / David Jablons, MD

3:45 Targeting the Cancer Stem Cell
Tina Li, MD, PhD

4:00 Questions

Chair: Heather Wakelee, MD
Panel: Sarita Dubey, MD/Derick Lau, MD

4:05 Small Cell Lung Cancer – Has There Been Any Progress in It’s Treatment
Derick Lau, MD, PhD

4:20 Questions

4:25 Case Presentation/Roundtable Discussion
Moderator: UC Davis Faculty

4:55 pm Questions/Closing Remarks/Evaluations

   Back To Top

David R. Gandara, MD
Professor of Medicine
Division of Hematology/Oncology
Associate Director of Clinical Research
Director, Thoracic Oncology Program
UC Davis Cancer Center

David M. Jablons, MD
Professor of Surgery
Chief, Section of General Thoracic
Surgery; Ada Distinguished Professor
and Program Leader
Thoracic Oncology Program
UCSF Comprehensive Cancer Center

   Back To Top

Michele Carbone, MD, PhD
Interim Director, Cancer
Research Center of Hawaii;
Professor and Chairman,
Department of Pathology,
John A. Burns School of
Medicine, University of Hawaii
Honolulu, HI


Heather Wakelee, MD
Assistant Professor of Medicine


Royce F. Calhoun, II MD
Assistant Professor of Surgery

Allen Chen, MD
Assistant Professor of Radiation

David T. Cooke, MD
Assistant Professor of Surgery

Primo N. “Lucky” Lara, Jr., MD
Associate Professor of Medicine

Tina Li, MD, PhD
Assistant Professor of Medicine

Derick Lau, MD, PhD
Professor of Medicine

Philip Mack, PhD
Assistant Research Geneticist

David K. Shelton, Jr., MD
Professor and Chief of Nuclear

Kenneth Yoneda, MD
Associate Professor of Medicine
Pulmonary Division


Guilherme M. Campos, MD
Assistant Professor in Residence

Sarita Dubey, MD
Assistant Professor of Medicine
Alexander Gottschalk, MD, PhD
Assistant Professor of Radiation

Thierry M. Jahan, MD
Associate Professor of Medicine

Andrew Ko, MD
Assistant Professor of Medicine

Jasleen Kukreja, MD
Assistant Professor of Surgery

Lorriana Leard, MD
Assistant Professor of
Pulmonary and Critical Care

Pierre Theodore, MD
Assistant Professor of Surgery

Sue S. Yom, MD
Assistant Professor of Radiation

   Back To Top

Travel & Lodging:
St. Regis San Francisco
125 3rd Street
San Francisco, CA 94103
415.284.4000 or 877 ST-REGIS

Hotel Rates: $230/night

   Back To Top

Cancellation Policy:
Refund Policy: Cancellations received in writing before the first day of the course will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date.

   Back To Top

Return to the course list.  

    Site Map    Contact Info     ©UC Regents